Latest: Deepak Nitrite Ltd Q1 FY27 results →All Q4 FY26 results →
DN

Deepak Nitrite Ltd

Q4 FY26Chemicals & Petrochemicals

Deepak Nitrite Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Price₹1,747
Market cap₹23.7K Cr
P/E29.9
Updated23 Aug 2026
Read3 min read

The short version

Advanced Intermediates segment expects healthy volume growth supported by stable domestic demand and improving pricing environment. FY27 is expected to show a stronger margin profile and improving earnings trends compared to FY26, driven by new downstream products, especially in agri-chemicals and advanced intermediates.

From Deepak Nitrite Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Advanced Intermediates segment expects healthy volume growth supported by stable domestic demand and improving pricing environment. (Page 5 and 11)
  • Phenolics segment anticipates better performance in Q1 FY27 over Q4 FY26 with high plant efficiencies and no feedstock constraints. (Page 12)
  • New products including fluorinated molecules and downstream chemistries to contribute to revenue from Q3 FY27 onwards. (Page 7 and 12)
  • Expansion projects like polycarbonate and agrochemical intermediates on track to support product diversification and margin improvement. (Pages 4, 6)

2 more points from Deepak Nitrite Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

Read what Deepak Nitrite Ltd said on margins in the Q4 FY26 call

Free account with your mobile number. We text a one-time code, no password.

Capital Expenditure Plans

  • Total announced project capex is around INR 11,000 crore, including multiple projects.
  • The Polycarbonate (PC) project is expected to be commissioned by June 2028.
  • Strategic investments are progressing as planned to support product diversification, import substitution, and margin improvement.
  • A dedicated on-site HyCO plant at the Dahej facility is being established via a long-term agreement with Praxair India under a Build-Own-Operate model to enhance execution visibility and reduce upfront investment.
  • Initiatives include expansions into downstream chemistries and integrated manufacturing capabilities.
  • New products including fluorinated molecules (INR 220 crore capex) have started production, targeting commercial scale by Q3 FY27.

2 more points from Deepak Nitrite Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Deepak Nitrite Ltd said on fundraising & capital structure — free account, 30 seconds.

Deepak Nitrite Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.1K Cr, net profit ₹220 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Indian Phosphate Ltd (Q4 FY26)

    H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In

  • Vishnu Chemicals Ltd (Q4 FY26)

    Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4

  • Rajputana Biodiesel Ltd (Q4 FY26)

    Revenue from Operations: ₹6,267.05 lakhs vs. Key investor presentation takeaways from Rajputana Bio.'s Q4 FY26 investor presentation — and how it ranks against

  • Neochem Bio Solutions Ltd (Q4 FY26)

    Capacity utilization improved from ~35% in FY24 to 53% in FY26, with significant headroom (47%) for growth without major capex. Key concall takeaways from…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Deepak Nitrite Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Deepak Nitrite Ltd Q4 FY26 results?

Advanced Intermediates segment expects healthy volume growth supported by stable domestic demand and improving pricing environment. FY27 is expected to show a stronger margin profile and improving earnings trends compared to FY26, driven by new downstream products, especially in agri-chemicals and advanced intermediates.

What is Deepak Nitrite Ltd share price analysis?

Deepak Nitrite Ltd currently shows a neutral. The stock trades at a P/E of 29.9 with a market cap of ₹23,687 Cr. Investors should review the full earnings analysis for detailed insights.

Is Deepak Nitrite Ltd planning capital expenditure?

Total announced project capex is around INR 11,000 crore, including multiple projects.

Keep Deepak Nitrite Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.